Nathaniel Horwitz

Nathaniel is the CEO of Hunterbrook Media and Hunterbrook Capital. He co-founded Hunterbrook after company-building and investing at the biotechnology/healthcare fund RA Capital, where he was the youngest Venture Partner by over a decade. At that firm, Nathaniel incubated four companies — ranging from AI-designed medicines for cancer to cell therapies for autoimmune diseases — and the fund grew from under $1B to over $10B. He has served on the board of directors at several companies and continues to volunteer as Executive Chair at Mayday, which he co-founded with Hunterbrook publisher Sam Koppelman and Hunterbrook advisor Liv Raisner. He has a degree in molecular biology from Harvard, where he co-authored biomedical research. He has published in The Washington Post, The Boston Globe, The Daily Beast, The Atlantic, The Harvard Crimson, The New York Times, and The Australian Financial Review. His first job out of high school was reporting for his local newspaper. In his role as CEO of Hunterbrook Media, he may contribute reporting or editorial input. Nathaniel is based in Brooklyn.